AI May Accelerate Discovery of Drugs for Brain Conditions Like MND
US Prioritizes American AI Expansion in Asia Following TrumpXi Meeting Official
Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Restrictions
Lowes Companies LOW Faces Price Target Reduction Amidst Market Adjustments
Shameful Imbalance Youth Benefit Spending Outpaces Job Investment Says Former Minister
SBIled Consortium Invites Bids for Essar Group Promoter Guarantees at Rs 200 Crore Reserve Price
AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline
FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline
WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility
RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Revenue Discrepancy
Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds
CBZ Q1 2026 Earnings EPS Surges 124 Above Estimates Driving Strong Profitability
Jeffs Brands Ltd Warrant JFBRW Surges 70 Whats Behind the Sharp Move
Inspire Medical Systems INSP Dips 2 as Stock Tests Key Support Levels
Claritev Corporation CTEV Dips Nearly 8 as Stock Tests Key Support Levels
Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142
Haleon HLN Holds Steady Near 929 Amid Modest Downside Support and Resistance in Focus
AI Wealth Must Benefit Public South Korea Deputy PM Warns Amid Samsung Labor Dispute
Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms
Wordle 1802 Hints Release Highlights NYT Puzzles Sustained Engagement
China Emerges as Primary Rival in Humanoid Robot Race Musk Says
Timex Group India Reports INR 800 Cr Revenue Marks 3x Growth in Four Years
TechLed Gains Lift SP 500 as Dow Slides on Sector Rotation
CRK Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds
Taylor Devices TAYD Modestly Gains as Shares Hold Above Key Support Level
Moelis Company Q1 2026 Earnings EPS Misses Estimates Amid Cautious Advisory Environment
Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines
EDAP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Operational Headwinds
Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress
ICE Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline
CDP Q1 2026 Earnings EPS Beats Estimates by 2 Stock Slips Modestly
GOGO Q1 2026 Earnings EPS Beat Highlights Cost Discipline Stock Edges Lower